Stay updated on Nivolumab for IDH Mutant Gliomas Clinical Trial
Sign up to get notified when there's something new on the Nivolumab for IDH Mutant Gliomas Clinical Trial page.

Latest updates to the Nivolumab for IDH Mutant Gliomas Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe page now states that no participants are being recruited anymore and updates the study duration references to up to 54 months. New sections for How to Read a Study Record, Common Questions, and How to Join a Study are added, and the Intervention/Treatment details are expanded.SummaryDifference0.9%

- Check21 days agoChange DetectedRevision label updated from v3.5.4 to v3.5.5 on the page, indicating a minor platform update.SummaryDifference0.1%

- Check42 days agoChange DetectedA new revision tag v3.5.4 was added, replacing the previous v3.5.3. This indicates the page has been updated to a newer revision.SummaryDifference0.1%

- Check56 days agoChange DetectedRevision: v3.5.3 replaces v3.5.2 on the page, signaling a version update. This update is a technical patch and does not change the study data or presented content.SummaryDifference0.1%

- Check71 days agoChange DetectedRevision indicator updated to v3.5.2; previous revision v3.5.0 was removed.SummaryDifference0.1%

- Check92 days agoChange DetectedAdded revision: v3.5.0. Deleted revision: v3.4.3.SummaryDifference0.1%

Stay in the know with updates to Nivolumab for IDH Mutant Gliomas Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab for IDH Mutant Gliomas Clinical Trial page.